Arcadia Medicine

Team

CEO and Founder

Nikita Obidin

VP of Regulatory Affairs

Gary Riordan

Chief of Staff

Jaclyn Chau

Head of Strategy and Ops

Serena Lim-Strutt

Core CMC Partner

Joan Connolly

Scientific Advisor

Boris Heifets

Scientific Advisor

Graham Pechenik

Strategic advisor

Josh Hardman

Strategic Advisor

Jamie Heywood

Strategic Advisor

Quentin Frerichs

Strategic Advisor

Sarah Sclarsic

backButton

CEO and Founder

Nikita Obidin

Nikita Obidin is the founder and CEO of Arcadia Medicine. While studying chemical engineering as an undergraduate, he first picked up a copy of Alexander Shulgin’s PIHKAL, which sparked a lifetime fascination with the chemistry and neuroscience of psychedelics. He did his graduate studies in Ed Boyden’s group at MIT, where he worked on expansion microscopy and long-read sequencing.

Vice President of Regulatory Affairs

Gary Riordan

Gary Riordan is the Vice President of Regulatory at Arcadia. Mr. Riordan is a regulatory industry veteran with over 30 years of commercialization/regulatory/quality experience. Gary has extensive global regulatory and quality experience, including serving as a primary reviewer at the U.S. Food and Drug Administration (FDA) and has held executive positions as Sr. V.P. and V.P. of Quality and Regulatory Affairs developed regulatory strategies (for IND’s, PLA’s, PMA’s and 510(k)’s). Gary has also initiated and advanced compliant quality systems and has served as the company lead for many successful FDA and ISO audits at multiple companies.

Chief of Staff

Jaclyn Chau

Jaclyn is the Chief of Staff at Arcadia Medicine. She has over 16+ years of experience across Sales, HR, Administrative Operations, and Investor Relations. She has extensive experience working at various startups and financial institutions prior to joining the psychedelic space.

Head of Strategy and Operations

Serena Lim-Strutt

Serena has a background in management consulting at McKinsey & Company, where she served healthcare, decarbonization, and startup clients. Prior to this, Serena studied Neuroscience and Philosophy at Duke University. She has a long-time passion for the psychedelics space, previously volunteering at MAPS and completing her thesis on the cognitive and personality associations of classical psychedelics.

Core CMC Partner

Joan Connolly

Joan Connolly is a 30-year biopharma veteran with a proven record of developing and launching new products. Joan has deep experience in pharmaceutical development, regulatory submissions, manufacturing and supply, quality operations and team building. At Arcadia, she is focused on process development and clinical manufacturing for our early-stage assets, with a long-term goal to deliver a cost-effective and reliable product manufacturing infrastructure and efficient operations for sustainable growth.